摘要 |
A compound of formula I wherein W is a bicyclic hetroaryl of the structure X is -O-, -S-, -SO<SUB>2</SUB>-, -CHR<SUP>5</SUP>-, -CHR<SUP>5</SUP>O-, -CHR<SUP>5</SUP>S-, -CHR<SUP>5</SUP>SO<SUB>2</SUB>-, -CHR<SUP>5</SUP>CO- or -CH<SUB>2</SUB>CHR<SUP>5</SUP>-; Y is a bond or -CHR<SUP>6</SUP>-; Z is an aryl or heteroaryl group of the following structure: A is -CH- or -N-; B is -O- or -S-; and R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>4</SUP>, R<SUP>5</SUP>, R<SUP>6</SUP>, R<SUP>7 </SUP>and R<SUP>8 </SUP>are as described herein. Further provided is a method for treating diabetes and related diseases employing a glycogen phosphorylase inhibiting amount of the above compound, either alone or in combination with another therapeutic agent.
|